Home

Treatment

Read time: 3 min

Congress highlights

Managing the patient with chronic migraine and medication overuse headache: a practical guide

During a panel discussion session at the 2022 American Headache Society Scottsdale Headache...

Read time: 3 min

Congress highlights

Real world evidence or clinical trials – what informs clinical practice the most?

In a scientific session at the 16th European Headache Congress, Vienna, Austria, the expert faculty...

Read time: 5 min

Assessing the value of antidepressants in depression

In a session titled ‘Antidepressants in Depression: What Do They Do and How Do They Do It?...

Key drivers of migraine disease progression

At EAN 2022, Gisela Terwindt, Professor of Neurology, Leiden University Medical Centre, discussed...

Read time: 3 min

Congress highlights

What can be done for patients with primary psychosis to achieve recovery?

Strategies aiming for recovery for patients with primary psychosis were presented by experts at WCP...

Read time: 3 min

Satellite symposium

Acute and preventive migraine therapies: an evolving therapeutic landscape

Failure to respond to at least some of the many acute and preventive treatments for migraine is not...

Read time: 3 min

Congress highlights

Highlights in depression research from APA Online 2022

Recent research findings in depression from the poster session at APA Online 2022 covered topics...

Neurotoriun

Neurotorium is your new point of reference for educational content on psychiatry, neurology, and neuroscience.

Country selection

We are registering that you are located in Brazil - if that's correct then please continue to Progress in Mind Brazil

Not located in Brazil?
Go to a different regional HUB

Continue to Progress in Mind Continue to Progress in Mind Brazil Continue to Progress in Mind MENA Continue to Progress in Mind Spain Continue to Progress in Mind Italy Continue to Progress in Mind Greece Continue to Progress in Mind South East Asia Continue to Progress in Mind Middle East & Africa Continue to Progress in Mind United Kingdom Continue to Progress in Mind Sweden Continue to Progress in Mind Norge Continue to Progress in Mind Denmark Continue to Progress in Mind Japan RC Continue to Progress in Mind България Continue to Progress in Mind Israel Continue to Progress in Mind Sweden Continue to Progress in Mind Finland Continue to Progress in Mind Ukraine Continue to Progress in Mind Belgium & Luxembourg Continue to Progress in Mind Switzerland Continue to Progress in Mind Germany Continue to Progress in Mind Austria

You are leaving Progress in Mind

Continue to

Cancel

Progress in Mind Belux

Accept Cancel

Login as a registered health care professional

Please enter your email to continue

Register as a health care professional

Please enter your email to continue

Hello
Please confirm your email

We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.

The information on this site is exclusively intended for health care professionals.

All the information included in the Website is related to diseases, investigations and existing or potential treatment options and, therefore, directed to health professionals . The technical information of the drugs is provided merely informative, being the responsibility of the professionals authorized to prescribe drugs and decide, in each concrete case, the most appropriate treatment to the needs of the patient.

Accept

Decline

Congress

Register for access to Progress in Mind in your country